Kolexia
Le Du Fanny Oncologie médicale
Le Du Fanny
Oncologie médicale
Centre Eugène Marquis
Rennes, France
70 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Carcinomes Tumeurs du sein triple-négatives Métastase tumorale Récidive tumorale locale Carcinome hépatocellulaire Tumeurs de l'ovaire Tumeurs de l'utérus Cellules tumorales circulantes

Collaborateurs

Voir plus
Bourien Heloise
Bourien Heloise
Centre Eugène Marquis, Rennes, France
Dieras Veronique
Dieras Veronique
Clcc Institut Curie, Paris, France
Crouzet Laurence
Crouzet Laurence
Centre Eugène Marquis, Rennes, France
Perrin Christophe
Perrin Christophe
Centre Eugène Marquis, Rennes, France

Industries

Voir plus
Novartis
46 collaboration(s)
Dernière en 2023
B3TSI
35 collaboration(s)
Dernière en 2022
Lilly
26 collaboration(s)
Dernière en 2023
Edimark
17 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Plasma-based analysis of ERBB2 mutational status by multiplex digital PCR in a large series of patients with metastatic breast cancer.
Molecular oncology   29 janvier 2024
SOFT: A Phase III Trial Evaluating the Role of Ovarian Function Suppression and the Role of Exemestane as Adjuvant Therapies for Premenopausal Women With Endocrine Responsive Breast Cancer
Essai Clinique (ETOP IBCSG Partners Foundation)   14 décembre 2023
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
The oncologist   11 octobre 2023
Management of trophoblastic tumors : review of evidence, current practice, and future directions.
Expert review of anticancer therapy   22 mai 2023
208P Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases: A subanalysis of the German brain metastases in breast cancer registry (BMBC)
Abstract Book of ESMO Breast Cancer 2023, Berlin, Germany, 11-13 May 2023   01 mai 2023
Development of sensitive and robust multiplex digital PCR assays for the detection of ESR1 mutations in the plasma of metastatic breast cancer patients.
Clinica chimica acta; international journal of clinical chemistry   25 avril 2023
Safety and efficacy of the anti-PD1 immunotherapy with nivolumab in trichoblastic carcinomas.
Cancer immunology, immunotherapy : CII   17 avril 2023
Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study.
Drugs - real world outcomes   11 janvier 2023
Selective internal radiation therapy in older patients with hepatocellular carcinoma: a retrospective analysis.
European journal of gastroenterology & hepatology   23 décembre 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.
ESMO open   21 décembre 2022